Chuanbin Yang

5.7k total citations · 2 hit papers
71 papers, 2.3k citations indexed

About

Chuanbin Yang is a scholar working on Epidemiology, Molecular Biology and Physiology. According to data from OpenAlex, Chuanbin Yang has authored 71 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 24 papers in Molecular Biology and 17 papers in Physiology. Recurrent topics in Chuanbin Yang's work include Autophagy in Disease and Therapy (20 papers), Alzheimer's disease research and treatments (11 papers) and Endoplasmic Reticulum Stress and Disease (10 papers). Chuanbin Yang is often cited by papers focused on Autophagy in Disease and Therapy (20 papers), Alzheimer's disease research and treatments (11 papers) and Endoplasmic Reticulum Stress and Disease (10 papers). Chuanbin Yang collaborates with scholars based in China, Hong Kong and Macao. Chuanbin Yang's co-authors include Jigang Wang, Ju‐Xian Song, Ashok Iyaswamy, Min Li, Sravan Gopalkrishnashetty Sreenivasmurthy, Jiahong Lu, Zhou Zhu, Benjamin Chun‐Kit Tong, King‐Ho Cheung and Han‐Ming Shen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Chuanbin Yang

67 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1

2021 233 citations Piao Luo, Dandan Liu et al. Acta Pharmaceutica Sinica B profile →
Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential

2022 121 citations Wei Zhang, Chengchao Xu et al. Acta Pharmaceutica Sinica B profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chuanbin Yang China	29	972	542	479	275	245	71	2.3k
Yajun Wu Singapore	25	1.0k 1.1×	802 1.5×	509 1.1×	229 0.8×	205 0.8×	57	2.5k
Ashok Iyaswamy Hong Kong	28	731 0.8×	523 1.0×	669 1.4×	198 0.7×	313 1.3×	64	2.1k
Chongxi Fan China	35	1.3k 1.3×	424 0.8×	476 1.0×	254 0.9×	143 0.6×	54	2.8k
Shouyin Di China	36	1.4k 1.5×	398 0.7×	431 0.9×	282 1.0×	143 0.6×	53	2.9k
Zhenxiao Jin China	33	1.6k 1.7×	512 0.9×	691 1.4×	317 1.2×	293 1.2×	94	3.7k
Liming Yu China	26	1.1k 1.2×	347 0.6×	517 1.1×	250 0.9×	204 0.8×	63	2.5k
Shanshan Yu China	32	1.6k 1.6×	323 0.6×	320 0.7×	393 1.4×	191 0.8×	93	2.8k
Wenming Li China	24	788 0.8×	305 0.6×	419 0.9×	210 0.8×	389 1.6×	54	1.8k
Hyun Ok Yang South Korea	30	1.1k 1.1×	237 0.4×	318 0.7×	125 0.5×	415 1.7×	95	2.4k
Yong Zhao China	28	1.2k 1.3×	260 0.5×	278 0.6×	244 0.9×	283 1.2×	100	2.5k

Countries citing papers authored by Chuanbin Yang

Since Specialization

Citations

This map shows the geographic impact of Chuanbin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanbin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanbin Yang more than expected).

Fields of papers citing papers by Chuanbin Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanbin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanbin Yang. The network helps show where Chuanbin Yang may publish in the future.

Co-authorship network of co-authors of Chuanbin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanbin Yang. A scholar is included among the top collaborators of Chuanbin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanbin Yang. Chuanbin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jaganathan, Ravindran, Ashok Iyaswamy, Senthilkumar Krishnamoorthi, et al.. (2025). Current aspects of targeting cellular senescence for the therapy of neurodegenerative diseases. Frontiers in Aging Neuroscience. 17. 1627921–1627921.

Luo, Piao, Junhui Chen, Ashok Iyaswamy, et al.. (2025). Glaucocalyxin A Induces Cytotoxicity in Renal Cancer Cells via ROS‐Mediated Autophagy by Direct Targeting of Antioxidant Enzymes PRDX1 and PRDX2. Advanced Biology. 9(11). e00031–e00031.

Yang, Chuanbin, et al.. (2025). Xixin Decoction’s novel mechanism for alleviating Alzheimer’s disease cognitive dysfunction by modulating amyloid-β transport across the blood–brain barrier to reduce neuroinflammation. Frontiers in Pharmacology. 15. 1508726–1508726. 2 indexed citations

Song, Yali, Junhui Chen, Siyu Xia, et al.. (2024). Integrated RNA sequencing and biochemical studies reveal endoplasmic reticulum stress and autophagy dysregulation contribute to Tri (2-Ethylhexyl) phosphate (TEHP)-induced cell injury in Sertoli cells. Environmental Pollution. 360. 124536–124536. 1 indexed citations

Bai, Yunmeng, Yali Song, Nan Xu, et al.. (2023). Dissection of molecular mechanisms of liver injury induced by microcystin-leucine arginine via single-cell RNA-sequencing. Journal of Environmental Sciences. 145. 164–179. 3 indexed citations

Zhang, Wei, Siyu Xia, Min Cao, et al.. (2023). A single-cell landscape of triptolide-associated testicular toxicity in mice. Journal of Pharmaceutical Analysis. 13(8). 880–893. 14 indexed citations

Bai, Yunmeng, Zhou Zhu, Wenqiao Zhang, et al.. (2023). Insight into Tetrabromobisphenol A‐Associated Liver Transcriptional Landscape via Single Cell RNA Sequencing. Advanced Biology. 8(2). e2300477–e2300477. 1 indexed citations

Xia, Peng, Haitao Yuan, Ming Tian, et al.. (2022). Surface‐Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo‐Photothermal Drugs for Gastric Cancer Theragnostic. Advanced Functional Materials. 33(7). 27 indexed citations

Zhang, Wei, Chengchao Xu, Jichao Sun, et al.. (2022). Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential. Acta Pharmaceutica Sinica B. 12(3). 1019–1040. 121 indexed citations breakdown →

10.

Zhang, Qian, Piao Luo, Jiayun Chen, et al.. (2022). Dissection of Targeting Molecular Mechanisms of Aristolochic Acid-induced Nephrotoxicity via a Combined Deconvolution Strategy of Chemoproteomics and Metabolomics. International Journal of Biological Sciences. 18(5). 2003–2017. 43 indexed citations

11.

Luo, Piao, Dandan Liu, Qian Zhang, et al.. (2021). Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1. Acta Pharmaceutica Sinica B. 12(5). 2300–2314. 233 indexed citations breakdown →

12.

Cai, Cui-Zan, Chuanbin Yang, Xu‐Xu Zhuang, et al.. (2020). NRBF2 is a RAB7 effector required for autophagosome maturation and mediates the association of APP-CTFs with active form of RAB7 for degradation. Autophagy. 17(5). 1112–1130. 34 indexed citations

13.

Malampati, Sandeep, Ju‐Xian Song, Benjamin Chun‐Kit Tong, et al.. (2020). Targeting Aggrephagy for the Treatment of Alzheimer’s Disease. Cells. 9(2). 311–311. 44 indexed citations

14.

Wang, Ziying, Chuanbin Yang, Jia Liu, et al.. (2020). A Curcumin Derivative Activates TFEB and Protects Against Parkinsonian Neurotoxicity in Vitro. International Journal of Molecular Sciences. 21(4). 1515–1515. 39 indexed citations

15.

Xiao, Yongwei, Jianing Zhong, Junyun Huang, et al.. (2020). Exosomes as potential sources of biomarkers in colorectal cancer. Cancer Letters. 476. 13–22. 144 indexed citations

16.

Iyaswamy, Ashok, Ju‐Xian Song, Chuanbin Yang, et al.. (2019). NeuroDefend, a novel Chinese medicine, attenuates amyloid-β and tau pathology in experimental Alzheimer's disease models. Journal of Food and Drug Analysis. 28(1). 132–146. 31 indexed citations

17.

Wang, Ziying, Jingyi Liu, Chuanbin Yang, et al.. (2017). Neuroprotective Natural Products for the Treatment of Parkinson's Disease by Targeting the Autophagy-Lysosome Pathway: A Systematic Review. Phytotherapy Research. 31(8). 1119–1127. 43 indexed citations

18.

Durairajan, Siva Sundara Kumar, Ashok Iyaswamy, Sandeep Malampati, et al.. (2017). A modified formulation of Huanglian-Jie-Du-Tang reduces memory impairments and β-amyloid plaques in a triple transgenic mouse model of Alzheimer’s disease. Scientific Reports. 7(1). 6238–6238. 35 indexed citations

19.

Yang, Chuanbin, Xuechen Li, & Jianhui Rong. (2014). Amygdalin isolated from Semen Persicae (Tao Ren) extracts induces the expression of follistatin in HepG2 and C2C12 cell lines. Chinese Medicine. 9(1). 23–23. 25 indexed citations

20.

Yang, Chuanbin, et al.. (2014). Biochemical mechanisms of bornyl caffeate induced cytotoxicity in rat pheochromocytoma PC12 cells. Chemico-Biological Interactions. 219. 133–142. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact